nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—TSPO—asthma	0.472	1	CbGaD
Zaleplon—CYP3A7-CYP3A51P—Salmeterol—asthma	0.0291	0.0825	CbGbCtD
Zaleplon—CYP3A7—Salmeterol—asthma	0.0291	0.0825	CbGbCtD
Zaleplon—CYP3A7—Fluticasone Propionate—asthma	0.0248	0.0702	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Fluticasone Propionate—asthma	0.0248	0.0702	CbGbCtD
Zaleplon—CYP3A5—Salmeterol—asthma	0.0219	0.0619	CbGbCtD
Zaleplon—CYP3A5—Beclomethasone—asthma	0.0219	0.0619	CbGbCtD
Zaleplon—CYP3A5—Fluticasone Propionate—asthma	0.0186	0.0526	CbGbCtD
Zaleplon—CYP3A4—Fluticasone furoate—asthma	0.0112	0.0319	CbGbCtD
Zaleplon—CYP3A4—Budesonide—asthma	0.01	0.0284	CbGbCtD
Zaleplon—CYP3A7—Hydrocortisone—asthma	0.00931	0.0264	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Hydrocortisone—asthma	0.00931	0.0264	CbGbCtD
Zaleplon—CYP3A4—Indacaterol—asthma	0.00917	0.026	CbGbCtD
Zaleplon—CYP3A4—Ciclesonide—asthma	0.00917	0.026	CbGbCtD
Zaleplon—CYP3A4—Flunisolide—asthma	0.00852	0.0241	CbGbCtD
Zaleplon—CYP3A4—Salbutamol—asthma	0.00852	0.0241	CbGbCtD
Zaleplon—CYP3A4—Salmeterol—asthma	0.00852	0.0241	CbGbCtD
Zaleplon—CYP3A4—Ipratropium bromide—asthma	0.0076	0.0215	CbGbCtD
Zaleplon—CYP3A4—Zileuton—asthma	0.0076	0.0215	CbGbCtD
Zaleplon—CYP3A4—Fluticasone Propionate—asthma	0.00725	0.0205	CbGbCtD
Zaleplon—CYP3A5—Hydrocortisone—asthma	0.00698	0.0198	CbGbCtD
Zaleplon—CYP3A4—Zafirlukast—asthma	0.00669	0.0189	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Dexamethasone—asthma	0.00579	0.0164	CbGbCtD
Zaleplon—CYP3A7—Dexamethasone—asthma	0.00579	0.0164	CbGbCtD
Zaleplon—CYP3A4—Tiotropium—asthma	0.00576	0.0163	CbGbCtD
Zaleplon—CYP3A4—Aminophylline—asthma	0.00549	0.0156	CbGbCtD
Zaleplon—CYP3A4—Theophylline—asthma	0.00516	0.0146	CbGbCtD
Zaleplon—CYP3A4—Montelukast—asthma	0.0049	0.0139	CbGbCtD
Zaleplon—CYP3A4—Loratadine—asthma	0.0049	0.0139	CbGbCtD
Zaleplon—CYP3A4—Methylprednisolone—asthma	0.00448	0.0127	CbGbCtD
Zaleplon—CYP3A5—Dexamethasone—asthma	0.00434	0.0123	CbGbCtD
Zaleplon—CYP3A4—Triamcinolone—asthma	0.00339	0.00961	CbGbCtD
Zaleplon—CYP3A4—Betamethasone—asthma	0.00291	0.00825	CbGbCtD
Zaleplon—CYP3A4—Prednisolone—asthma	0.00287	0.00814	CbGbCtD
Zaleplon—CYP3A4—Hydrocortisone—asthma	0.00272	0.00771	CbGbCtD
Zaleplon—CYP3A4—Prednisone—asthma	0.00271	0.00768	CbGbCtD
Zaleplon—CYP3A4—Dexamethasone—asthma	0.00169	0.0048	CbGbCtD
Zaleplon—TSPO—exocrine gland—asthma	0.000503	0.116	CbGeAlD
Zaleplon—TSPO—respiratory system—asthma	0.000262	0.0601	CbGeAlD
Zaleplon—AOX1—adrenal cortex—asthma	0.000257	0.0591	CbGeAlD
Zaleplon—AOX1—bronchus—asthma	0.000252	0.0579	CbGeAlD
Zaleplon—GABRB3—respiratory system—asthma	0.000238	0.0546	CbGeAlD
Zaleplon—AOX1—trachea—asthma	0.000227	0.052	CbGeAlD
Zaleplon—TSPO—adrenal cortex—asthma	0.00022	0.0505	CbGeAlD
Zaleplon—TSPO—epithelium—asthma	0.000219	0.0503	CbGeAlD
Zaleplon—TSPO—bronchus—asthma	0.000216	0.0495	CbGeAlD
Zaleplon—TSPO—smooth muscle tissue—asthma	0.000211	0.0484	CbGeAlD
Zaleplon—TSPO—cardiovascular system—asthma	0.000201	0.0461	CbGeAlD
Zaleplon—TSPO—trachea—asthma	0.000194	0.0444	CbGeAlD
Zaleplon—AOX1—adrenal gland—asthma	0.000186	0.0426	CbGeAlD
Zaleplon—GABRA2—adrenal gland—asthma	0.000171	0.0394	CbGeAlD
Zaleplon—GABRB2—lung—asthma	0.000164	0.0378	CbGeAlD
Zaleplon—AOX1—lung—asthma	0.000163	0.0374	CbGeAlD
Zaleplon—CYP3A5—respiratory system—asthma	0.000162	0.0372	CbGeAlD
Zaleplon—TSPO—adrenal gland—asthma	0.000159	0.0364	CbGeAlD
Zaleplon—TSPO—lung—asthma	0.000139	0.0319	CbGeAlD
Zaleplon—GABRB3—lung—asthma	0.000126	0.029	CbGeAlD
Zaleplon—CYP3A5—lung—asthma	8.61e-05	0.0198	CbGeAlD
Zaleplon—Back pain—Triamcinolone—asthma	2.91e-05	0.000176	CcSEcCtD
Zaleplon—Malaise—Hydrocortisone—asthma	2.88e-05	0.000174	CcSEcCtD
Zaleplon—Loss of consciousness—Prednisolone—asthma	2.87e-05	0.000174	CcSEcCtD
Zaleplon—Vertigo—Hydrocortisone—asthma	2.87e-05	0.000174	CcSEcCtD
Zaleplon—Nausea—Montelukast—asthma	2.87e-05	0.000173	CcSEcCtD
Zaleplon—Syncope—Hydrocortisone—asthma	2.86e-05	0.000173	CcSEcCtD
Zaleplon—Rash—Budesonide—asthma	2.84e-05	0.000172	CcSEcCtD
Zaleplon—Dermatitis—Budesonide—asthma	2.84e-05	0.000172	CcSEcCtD
Zaleplon—Headache—Budesonide—asthma	2.82e-05	0.000171	CcSEcCtD
Zaleplon—Hypertension—Prednisolone—asthma	2.82e-05	0.000171	CcSEcCtD
Zaleplon—Loss of consciousness—Hydrocortisone—asthma	2.81e-05	0.00017	CcSEcCtD
Zaleplon—Ill-defined disorder—Triamcinolone—asthma	2.79e-05	0.000169	CcSEcCtD
Zaleplon—Ill-defined disorder—Methylprednisolone—asthma	2.78e-05	0.000168	CcSEcCtD
Zaleplon—Alopecia—Betamethasone—asthma	2.77e-05	0.000168	CcSEcCtD
Zaleplon—Alopecia—Dexamethasone—asthma	2.77e-05	0.000168	CcSEcCtD
Zaleplon—Nausea—Salbutamol—asthma	2.76e-05	0.000167	CcSEcCtD
Zaleplon—Hypertension—Hydrocortisone—asthma	2.76e-05	0.000167	CcSEcCtD
Zaleplon—Discomfort—Prednisolone—asthma	2.75e-05	0.000166	CcSEcCtD
Zaleplon—Angioedema—Triamcinolone—asthma	2.75e-05	0.000166	CcSEcCtD
Zaleplon—Angioedema—Methylprednisolone—asthma	2.74e-05	0.000166	CcSEcCtD
Zaleplon—Myalgia—Hydrocortisone—asthma	2.72e-05	0.000164	CcSEcCtD
Zaleplon—Hallucination—Prednisone—asthma	2.72e-05	0.000164	CcSEcCtD
Zaleplon—Malaise—Triamcinolone—asthma	2.71e-05	0.000164	CcSEcCtD
Zaleplon—Anxiety—Hydrocortisone—asthma	2.71e-05	0.000164	CcSEcCtD
Zaleplon—Malaise—Methylprednisolone—asthma	2.71e-05	0.000164	CcSEcCtD
Zaleplon—Vertigo—Triamcinolone—asthma	2.7e-05	0.000163	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	2.7e-05	0.000163	CcSEcCtD
Zaleplon—Syncope—Triamcinolone—asthma	2.7e-05	0.000163	CcSEcCtD
Zaleplon—Vertigo—Methylprednisolone—asthma	2.7e-05	0.000163	CcSEcCtD
Zaleplon—Syncope—Methylprednisolone—asthma	2.69e-05	0.000163	CcSEcCtD
Zaleplon—Discomfort—Hydrocortisone—asthma	2.69e-05	0.000163	CcSEcCtD
Zaleplon—Nausea—Budesonide—asthma	2.68e-05	0.000162	CcSEcCtD
Zaleplon—Anaphylactic shock—Prednisolone—asthma	2.67e-05	0.000161	CcSEcCtD
Zaleplon—Oedema—Prednisolone—asthma	2.67e-05	0.000161	CcSEcCtD
Zaleplon—Loss of consciousness—Triamcinolone—asthma	2.64e-05	0.00016	CcSEcCtD
Zaleplon—Loss of consciousness—Methylprednisolone—asthma	2.64e-05	0.00016	CcSEcCtD
Zaleplon—Shock—Prednisolone—asthma	2.63e-05	0.000159	CcSEcCtD
Zaleplon—Oedema—Hydrocortisone—asthma	2.61e-05	0.000158	CcSEcCtD
Zaleplon—Anaphylactic shock—Hydrocortisone—asthma	2.61e-05	0.000158	CcSEcCtD
Zaleplon—Tachycardia—Prednisolone—asthma	2.6e-05	0.000158	CcSEcCtD
Zaleplon—Hypertension—Triamcinolone—asthma	2.6e-05	0.000157	CcSEcCtD
Zaleplon—Hypertension—Methylprednisolone—asthma	2.59e-05	0.000157	CcSEcCtD
Zaleplon—Hyperhidrosis—Prednisolone—asthma	2.58e-05	0.000156	CcSEcCtD
Zaleplon—Shock—Hydrocortisone—asthma	2.56e-05	0.000155	CcSEcCtD
Zaleplon—Myalgia—Triamcinolone—asthma	2.56e-05	0.000155	CcSEcCtD
Zaleplon—Nervous system disorder—Hydrocortisone—asthma	2.56e-05	0.000155	CcSEcCtD
Zaleplon—CYP3A4—Metapathway biotransformation—HNMT—asthma	2.56e-05	0.0046	CbGpPWpGaD
Zaleplon—Arthralgia—Methylprednisolone—asthma	2.55e-05	0.000155	CcSEcCtD
Zaleplon—Myalgia—Methylprednisolone—asthma	2.55e-05	0.000155	CcSEcCtD
Zaleplon—Eye disorder—Prednisone—asthma	2.55e-05	0.000154	CcSEcCtD
Zaleplon—Anxiety—Methylprednisolone—asthma	2.55e-05	0.000154	CcSEcCtD
Zaleplon—Tachycardia—Hydrocortisone—asthma	2.54e-05	0.000154	CcSEcCtD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—TACR1—asthma	2.54e-05	0.00458	CbGpPWpGaD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	2.54e-05	0.000153	CcSEcCtD
Zaleplon—Skin disorder—Hydrocortisone—asthma	2.53e-05	0.000153	CcSEcCtD
Zaleplon—Ill-defined disorder—Dexamethasone—asthma	2.53e-05	0.000153	CcSEcCtD
Zaleplon—Ill-defined disorder—Betamethasone—asthma	2.53e-05	0.000153	CcSEcCtD
Zaleplon—Discomfort—Triamcinolone—asthma	2.53e-05	0.000153	CcSEcCtD
Zaleplon—Discomfort—Methylprednisolone—asthma	2.52e-05	0.000153	CcSEcCtD
Zaleplon—Hyperhidrosis—Hydrocortisone—asthma	2.52e-05	0.000152	CcSEcCtD
Zaleplon—Dry mouth—Triamcinolone—asthma	2.5e-05	0.000151	CcSEcCtD
Zaleplon—Angioedema—Dexamethasone—asthma	2.49e-05	0.000151	CcSEcCtD
Zaleplon—Angioedema—Betamethasone—asthma	2.49e-05	0.000151	CcSEcCtD
Zaleplon—Anorexia—Hydrocortisone—asthma	2.48e-05	0.00015	CcSEcCtD
Zaleplon—Confusional state—Methylprednisolone—asthma	2.47e-05	0.000149	CcSEcCtD
Zaleplon—Immune system disorder—Prednisone—asthma	2.47e-05	0.000149	CcSEcCtD
Zaleplon—Malaise—Dexamethasone—asthma	2.46e-05	0.000149	CcSEcCtD
Zaleplon—Malaise—Betamethasone—asthma	2.46e-05	0.000149	CcSEcCtD
Zaleplon—Oedema—Triamcinolone—asthma	2.45e-05	0.000148	CcSEcCtD
Zaleplon—Anaphylactic shock—Triamcinolone—asthma	2.45e-05	0.000148	CcSEcCtD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY2—asthma	2.45e-05	0.00442	CbGpPWpGaD
Zaleplon—Vertigo—Betamethasone—asthma	2.45e-05	0.000148	CcSEcCtD
Zaleplon—Vertigo—Dexamethasone—asthma	2.45e-05	0.000148	CcSEcCtD
Zaleplon—CYP3A4—Estrogen metabolism—GSTM1—asthma	2.45e-05	0.00441	CbGpPWpGaD
Zaleplon—Anaphylactic shock—Methylprednisolone—asthma	2.45e-05	0.000148	CcSEcCtD
Zaleplon—Syncope—Betamethasone—asthma	2.45e-05	0.000148	CcSEcCtD
Zaleplon—Syncope—Dexamethasone—asthma	2.45e-05	0.000148	CcSEcCtD
Zaleplon—Hypotension—Hydrocortisone—asthma	2.44e-05	0.000147	CcSEcCtD
Zaleplon—Shock—Triamcinolone—asthma	2.41e-05	0.000146	CcSEcCtD
Zaleplon—Insomnia—Prednisolone—asthma	2.41e-05	0.000146	CcSEcCtD
Zaleplon—Alopecia—Prednisone—asthma	2.41e-05	0.000146	CcSEcCtD
Zaleplon—Shock—Methylprednisolone—asthma	2.41e-05	0.000146	CcSEcCtD
Zaleplon—Nervous system disorder—Methylprednisolone—asthma	2.4e-05	0.000145	CcSEcCtD
Zaleplon—Loss of consciousness—Dexamethasone—asthma	2.4e-05	0.000145	CcSEcCtD
Zaleplon—Loss of consciousness—Betamethasone—asthma	2.4e-05	0.000145	CcSEcCtD
Zaleplon—Paraesthesia—Prednisolone—asthma	2.4e-05	0.000145	CcSEcCtD
Zaleplon—Tachycardia—Triamcinolone—asthma	2.4e-05	0.000145	CcSEcCtD
Zaleplon—Mental disorder—Prednisone—asthma	2.39e-05	0.000145	CcSEcCtD
Zaleplon—Tachycardia—Methylprednisolone—asthma	2.39e-05	0.000145	CcSEcCtD
Zaleplon—GABRB2—Transmission across Chemical Synapses—ALDH2—asthma	2.38e-05	0.00429	CbGpPWpGaD
Zaleplon—Skin disorder—Methylprednisolone—asthma	2.38e-05	0.000144	CcSEcCtD
Zaleplon—Malnutrition—Prednisone—asthma	2.38e-05	0.000144	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Hydrocortisone—asthma	2.37e-05	0.000144	CcSEcCtD
Zaleplon—Hyperhidrosis—Triamcinolone—asthma	2.37e-05	0.000144	CcSEcCtD
Zaleplon—Hyperhidrosis—Methylprednisolone—asthma	2.37e-05	0.000143	CcSEcCtD
Zaleplon—Insomnia—Hydrocortisone—asthma	2.36e-05	0.000143	CcSEcCtD
Zaleplon—Hypertension—Dexamethasone—asthma	2.36e-05	0.000143	CcSEcCtD
Zaleplon—Hypertension—Betamethasone—asthma	2.36e-05	0.000143	CcSEcCtD
Zaleplon—Paraesthesia—Hydrocortisone—asthma	2.34e-05	0.000142	CcSEcCtD
Zaleplon—GABRA1—Transmission across Chemical Synapses—CHAT—asthma	2.34e-05	0.00421	CbGpPWpGaD
Zaleplon—Myalgia—Betamethasone—asthma	2.32e-05	0.000141	CcSEcCtD
Zaleplon—Myalgia—Dexamethasone—asthma	2.32e-05	0.000141	CcSEcCtD
Zaleplon—GABRA1—Transmembrane transport of small molecules—TRPA1—asthma	2.32e-05	0.00418	CbGpPWpGaD
Zaleplon—Anxiety—Betamethasone—asthma	2.31e-05	0.00014	CcSEcCtD
Zaleplon—Anxiety—Dexamethasone—asthma	2.31e-05	0.00014	CcSEcCtD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY2—asthma	2.3e-05	0.00414	CbGpPWpGaD
Zaleplon—Discomfort—Dexamethasone—asthma	2.29e-05	0.000139	CcSEcCtD
Zaleplon—Discomfort—Betamethasone—asthma	2.29e-05	0.000139	CcSEcCtD
Zaleplon—Dyspepsia—Hydrocortisone—asthma	2.29e-05	0.000139	CcSEcCtD
Zaleplon—Hypotension—Methylprednisolone—asthma	2.29e-05	0.000138	CcSEcCtD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY2—asthma	2.29e-05	0.00412	CbGpPWpGaD
Zaleplon—Pain—Prednisolone—asthma	2.28e-05	0.000138	CcSEcCtD
Zaleplon—Decreased appetite—Hydrocortisone—asthma	2.27e-05	0.000137	CcSEcCtD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL13—asthma	2.25e-05	0.00406	CbGpPWpGaD
Zaleplon—Gastrointestinal disorder—Hydrocortisone—asthma	2.25e-05	0.000136	CcSEcCtD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY2—asthma	2.24e-05	0.00404	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—CHAT—asthma	2.24e-05	0.00404	CbGpPWpGaD
Zaleplon—Musculoskeletal discomfort—Triamcinolone—asthma	2.24e-05	0.000135	CcSEcCtD
Zaleplon—GABRA2—Transmission across Chemical Synapses—ALDH2—asthma	2.24e-05	0.00403	CbGpPWpGaD
Zaleplon—Musculoskeletal discomfort—Methylprednisolone—asthma	2.23e-05	0.000135	CcSEcCtD
Zaleplon—Pain—Hydrocortisone—asthma	2.23e-05	0.000135	CcSEcCtD
Zaleplon—Oedema—Betamethasone—asthma	2.23e-05	0.000135	CcSEcCtD
Zaleplon—Anaphylactic shock—Betamethasone—asthma	2.23e-05	0.000135	CcSEcCtD
Zaleplon—Anaphylactic shock—Dexamethasone—asthma	2.23e-05	0.000135	CcSEcCtD
Zaleplon—Oedema—Dexamethasone—asthma	2.23e-05	0.000135	CcSEcCtD
Zaleplon—GABRB3—Transmission across Chemical Synapses—ALDH2—asthma	2.22e-05	0.004	CbGpPWpGaD
Zaleplon—Insomnia—Triamcinolone—asthma	2.22e-05	0.000134	CcSEcCtD
Zaleplon—Insomnia—Methylprednisolone—asthma	2.21e-05	0.000134	CcSEcCtD
Zaleplon—Ill-defined disorder—Prednisone—asthma	2.2e-05	0.000133	CcSEcCtD
Zaleplon—Paraesthesia—Triamcinolone—asthma	2.2e-05	0.000133	CcSEcCtD
Zaleplon—Feeling abnormal—Prednisolone—asthma	2.2e-05	0.000133	CcSEcCtD
Zaleplon—Paraesthesia—Methylprednisolone—asthma	2.2e-05	0.000133	CcSEcCtD
Zaleplon—Anaemia—Prednisone—asthma	2.2e-05	0.000133	CcSEcCtD
Zaleplon—Shock—Betamethasone—asthma	2.19e-05	0.000133	CcSEcCtD
Zaleplon—Shock—Dexamethasone—asthma	2.19e-05	0.000133	CcSEcCtD
Zaleplon—Dyspnoea—Triamcinolone—asthma	2.19e-05	0.000132	CcSEcCtD
Zaleplon—Nervous system disorder—Dexamethasone—asthma	2.18e-05	0.000132	CcSEcCtD
Zaleplon—Nervous system disorder—Betamethasone—asthma	2.18e-05	0.000132	CcSEcCtD
Zaleplon—Agitation—Prednisone—asthma	2.18e-05	0.000132	CcSEcCtD
Zaleplon—GABRG2—Transmission across Chemical Synapses—ALDH2—asthma	2.18e-05	0.00393	CbGpPWpGaD
Zaleplon—Tachycardia—Dexamethasone—asthma	2.17e-05	0.000131	CcSEcCtD
Zaleplon—Tachycardia—Betamethasone—asthma	2.17e-05	0.000131	CcSEcCtD
Zaleplon—Angioedema—Prednisone—asthma	2.17e-05	0.000131	CcSEcCtD
Zaleplon—Dyspepsia—Triamcinolone—asthma	2.16e-05	0.000131	CcSEcCtD
Zaleplon—Dyspepsia—Methylprednisolone—asthma	2.16e-05	0.00013	CcSEcCtD
Zaleplon—Hyperhidrosis—Dexamethasone—asthma	2.15e-05	0.00013	CcSEcCtD
Zaleplon—Hyperhidrosis—Betamethasone—asthma	2.15e-05	0.00013	CcSEcCtD
Zaleplon—Feeling abnormal—Hydrocortisone—asthma	2.15e-05	0.00013	CcSEcCtD
Zaleplon—Malaise—Prednisone—asthma	2.14e-05	0.00013	CcSEcCtD
Zaleplon—Vertigo—Prednisone—asthma	2.13e-05	0.000129	CcSEcCtD
Zaleplon—Gastrointestinal pain—Hydrocortisone—asthma	2.13e-05	0.000129	CcSEcCtD
Zaleplon—Syncope—Prednisone—asthma	2.13e-05	0.000129	CcSEcCtD
Zaleplon—Anorexia—Dexamethasone—asthma	2.12e-05	0.000128	CcSEcCtD
Zaleplon—Anorexia—Betamethasone—asthma	2.12e-05	0.000128	CcSEcCtD
Zaleplon—Urticaria—Prednisolone—asthma	2.12e-05	0.000128	CcSEcCtD
Zaleplon—GABRA2—Neuronal System—CHAT—asthma	2.1e-05	0.00378	CbGpPWpGaD
Zaleplon—Pain—Triamcinolone—asthma	2.1e-05	0.000127	CcSEcCtD
Zaleplon—Loss of consciousness—Prednisone—asthma	2.09e-05	0.000126	CcSEcCtD
Zaleplon—GABRB3—Neuronal System—CHAT—asthma	2.09e-05	0.00376	CbGpPWpGaD
Zaleplon—Hypotension—Betamethasone—asthma	2.08e-05	0.000126	CcSEcCtD
Zaleplon—Hypotension—Dexamethasone—asthma	2.08e-05	0.000126	CcSEcCtD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—TAC1—asthma	2.07e-05	0.00373	CbGpPWpGaD
Zaleplon—Urticaria—Hydrocortisone—asthma	2.07e-05	0.000125	CcSEcCtD
Zaleplon—Body temperature increased—Hydrocortisone—asthma	2.06e-05	0.000125	CcSEcCtD
Zaleplon—Abdominal pain—Hydrocortisone—asthma	2.06e-05	0.000125	CcSEcCtD
Zaleplon—Hypertension—Prednisone—asthma	2.05e-05	0.000124	CcSEcCtD
Zaleplon—GABRG2—Neuronal System—CHAT—asthma	2.05e-05	0.00369	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—GATA3—asthma	2.03e-05	0.00366	CbGpPWpGaD
Zaleplon—Musculoskeletal discomfort—Betamethasone—asthma	2.03e-05	0.000123	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Dexamethasone—asthma	2.03e-05	0.000123	CcSEcCtD
Zaleplon—Myalgia—Prednisone—asthma	2.02e-05	0.000122	CcSEcCtD
Zaleplon—Arthralgia—Prednisone—asthma	2.02e-05	0.000122	CcSEcCtD
Zaleplon—Feeling abnormal—Triamcinolone—asthma	2.02e-05	0.000122	CcSEcCtD
Zaleplon—Feeling abnormal—Methylprednisolone—asthma	2.02e-05	0.000122	CcSEcCtD
Zaleplon—Anxiety—Prednisone—asthma	2.02e-05	0.000122	CcSEcCtD
Zaleplon—Insomnia—Dexamethasone—asthma	2.01e-05	0.000122	CcSEcCtD
Zaleplon—Insomnia—Betamethasone—asthma	2.01e-05	0.000122	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	2.01e-05	0.000122	CcSEcCtD
Zaleplon—Gastrointestinal pain—Methylprednisolone—asthma	2e-05	0.000121	CcSEcCtD
Zaleplon—GABRB3—BDNF signaling pathway—NTRK1—asthma	2e-05	0.00361	CbGpPWpGaD
Zaleplon—Paraesthesia—Dexamethasone—asthma	2e-05	0.000121	CcSEcCtD
Zaleplon—Paraesthesia—Betamethasone—asthma	2e-05	0.000121	CcSEcCtD
Zaleplon—Discomfort—Prednisone—asthma	2e-05	0.000121	CcSEcCtD
Zaleplon—CYP3A7—Biological oxidations—ALDH2—asthma	1.98e-05	0.00356	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL1RN—asthma	1.97e-05	0.00354	CbGpPWpGaD
Zaleplon—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—asthma	1.97e-05	0.00354	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY2—asthma	1.96e-05	0.00353	CbGpPWpGaD
Zaleplon—Dyspepsia—Dexamethasone—asthma	1.96e-05	0.000119	CcSEcCtD
Zaleplon—Dyspepsia—Betamethasone—asthma	1.96e-05	0.000119	CcSEcCtD
Zaleplon—Urticaria—Triamcinolone—asthma	1.95e-05	0.000118	CcSEcCtD
Zaleplon—Urticaria—Methylprednisolone—asthma	1.95e-05	0.000118	CcSEcCtD
Zaleplon—Body temperature increased—Triamcinolone—asthma	1.94e-05	0.000117	CcSEcCtD
Zaleplon—Oedema—Prednisone—asthma	1.94e-05	0.000117	CcSEcCtD
Zaleplon—Anaphylactic shock—Prednisone—asthma	1.94e-05	0.000117	CcSEcCtD
Zaleplon—Abdominal pain—Methylprednisolone—asthma	1.94e-05	0.000117	CcSEcCtD
Zaleplon—Decreased appetite—Betamethasone—asthma	1.94e-05	0.000117	CcSEcCtD
Zaleplon—Decreased appetite—Dexamethasone—asthma	1.94e-05	0.000117	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Betamethasone—asthma	1.92e-05	0.000116	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Dexamethasone—asthma	1.92e-05	0.000116	CcSEcCtD
Zaleplon—CYP3A4—Tryptophan metabolism—ALDH2—asthma	1.91e-05	0.00344	CbGpPWpGaD
Zaleplon—Shock—Prednisone—asthma	1.91e-05	0.000115	CcSEcCtD
Zaleplon—GABRA1—Transmission across Chemical Synapses—ALDH2—asthma	1.91e-05	0.00343	CbGpPWpGaD
Zaleplon—Pain—Betamethasone—asthma	1.9e-05	0.000115	CcSEcCtD
Zaleplon—Pain—Dexamethasone—asthma	1.9e-05	0.000115	CcSEcCtD
Zaleplon—Nervous system disorder—Prednisone—asthma	1.9e-05	0.000115	CcSEcCtD
Zaleplon—Tachycardia—Prednisone—asthma	1.89e-05	0.000115	CcSEcCtD
Zaleplon—Skin disorder—Prednisone—asthma	1.88e-05	0.000114	CcSEcCtD
Zaleplon—CYP3A7—Biological oxidations—GSTT1—asthma	1.88e-05	0.00339	CbGpPWpGaD
Zaleplon—Hyperhidrosis—Prednisone—asthma	1.87e-05	0.000113	CcSEcCtD
Zaleplon—Asthenia—Hydrocortisone—asthma	1.87e-05	0.000113	CcSEcCtD
Zaleplon—Anorexia—Prednisone—asthma	1.85e-05	0.000112	CcSEcCtD
Zaleplon—GABRB2—Transmission across Chemical Synapses—ADCY2—asthma	1.84e-05	0.00332	CbGpPWpGaD
Zaleplon—Pruritus—Hydrocortisone—asthma	1.84e-05	0.000112	CcSEcCtD
Zaleplon—Feeling abnormal—Betamethasone—asthma	1.83e-05	0.000111	CcSEcCtD
Zaleplon—Feeling abnormal—Dexamethasone—asthma	1.83e-05	0.000111	CcSEcCtD
Zaleplon—GABRB3—BDNF signaling pathway—BDNF—asthma	1.83e-05	0.0033	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—ALDH2—asthma	1.83e-05	0.00329	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—ESR2—asthma	1.82e-05	0.00329	CbGpPWpGaD
Zaleplon—Gastrointestinal pain—Dexamethasone—asthma	1.82e-05	0.00011	CcSEcCtD
Zaleplon—Gastrointestinal pain—Betamethasone—asthma	1.82e-05	0.00011	CcSEcCtD
Zaleplon—GABRA1—Neuronal System—CHAT—asthma	1.79e-05	0.00323	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—LTC4S—asthma	1.78e-05	0.0032	CbGpPWpGaD
Zaleplon—Urticaria—Betamethasone—asthma	1.77e-05	0.000107	CcSEcCtD
Zaleplon—Urticaria—Dexamethasone—asthma	1.77e-05	0.000107	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Prednisone—asthma	1.77e-05	0.000107	CcSEcCtD
Zaleplon—Dizziness—Prednisolone—asthma	1.76e-05	0.000107	CcSEcCtD
Zaleplon—Asthenia—Triamcinolone—asthma	1.76e-05	0.000107	CcSEcCtD
Zaleplon—Abdominal pain—Betamethasone—asthma	1.76e-05	0.000106	CcSEcCtD
Zaleplon—Body temperature increased—Dexamethasone—asthma	1.76e-05	0.000106	CcSEcCtD
Zaleplon—Body temperature increased—Betamethasone—asthma	1.76e-05	0.000106	CcSEcCtD
Zaleplon—Abdominal pain—Dexamethasone—asthma	1.76e-05	0.000106	CcSEcCtD
Zaleplon—Asthenia—Methylprednisolone—asthma	1.76e-05	0.000106	CcSEcCtD
Zaleplon—Insomnia—Prednisone—asthma	1.75e-05	0.000106	CcSEcCtD
Zaleplon—Paraesthesia—Prednisone—asthma	1.74e-05	0.000105	CcSEcCtD
Zaleplon—Pruritus—Triamcinolone—asthma	1.74e-05	0.000105	CcSEcCtD
Zaleplon—Pruritus—Methylprednisolone—asthma	1.73e-05	0.000105	CcSEcCtD
Zaleplon—GABRA2—Transmission across Chemical Synapses—ADCY2—asthma	1.73e-05	0.00311	CbGpPWpGaD
Zaleplon—Dizziness—Hydrocortisone—asthma	1.72e-05	0.000104	CcSEcCtD
Zaleplon—GABRB3—Transmission across Chemical Synapses—ADCY2—asthma	1.72e-05	0.00309	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—ALDH2—asthma	1.71e-05	0.00308	CbGpPWpGaD
Zaleplon—Dyspepsia—Prednisone—asthma	1.71e-05	0.000103	CcSEcCtD
Zaleplon—GABRB3—Neuronal System—ALDH2—asthma	1.7e-05	0.00306	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—ADCY2—asthma	1.69e-05	0.00304	CbGpPWpGaD
Zaleplon—Decreased appetite—Prednisone—asthma	1.69e-05	0.000102	CcSEcCtD
Zaleplon—Rash—Prednisolone—asthma	1.68e-05	0.000102	CcSEcCtD
Zaleplon—Dermatitis—Prednisolone—asthma	1.68e-05	0.000102	CcSEcCtD
Zaleplon—Headache—Prednisolone—asthma	1.67e-05	0.000101	CcSEcCtD
Zaleplon—GABRG2—Neuronal System—ALDH2—asthma	1.67e-05	0.00301	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—SLC26A4—asthma	1.67e-05	0.003	CbGpPWpGaD
Zaleplon—Constipation—Prednisone—asthma	1.66e-05	0.0001	CcSEcCtD
Zaleplon—Rash—Hydrocortisone—asthma	1.64e-05	9.94e-05	CcSEcCtD
Zaleplon—Dermatitis—Hydrocortisone—asthma	1.64e-05	9.93e-05	CcSEcCtD
Zaleplon—Headache—Hydrocortisone—asthma	1.63e-05	9.88e-05	CcSEcCtD
Zaleplon—Dizziness—Triamcinolone—asthma	1.62e-05	9.82e-05	CcSEcCtD
Zaleplon—Dizziness—Methylprednisolone—asthma	1.62e-05	9.8e-05	CcSEcCtD
Zaleplon—GABRB3—BDNF signaling pathway—PPP2CA—asthma	1.61e-05	0.0029	CbGpPWpGaD
Zaleplon—Feeling abnormal—Prednisone—asthma	1.6e-05	9.67e-05	CcSEcCtD
Zaleplon—Asthenia—Dexamethasone—asthma	1.6e-05	9.67e-05	CcSEcCtD
Zaleplon—Asthenia—Betamethasone—asthma	1.6e-05	9.67e-05	CcSEcCtD
Zaleplon—CYP3A7—Phase 1 - Functionalization of compounds—POMC—asthma	1.59e-05	0.00287	CbGpPWpGaD
Zaleplon—Gastrointestinal pain—Prednisone—asthma	1.59e-05	9.59e-05	CcSEcCtD
Zaleplon—Nausea—Prednisolone—asthma	1.59e-05	9.59e-05	CcSEcCtD
Zaleplon—Pruritus—Betamethasone—asthma	1.58e-05	9.53e-05	CcSEcCtD
Zaleplon—Pruritus—Dexamethasone—asthma	1.58e-05	9.53e-05	CcSEcCtD
Zaleplon—GABRA2—Transmembrane transport of small molecules—SLC26A4—asthma	1.56e-05	0.00281	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—SLC26A4—asthma	1.55e-05	0.0028	CbGpPWpGaD
Zaleplon—Nausea—Hydrocortisone—asthma	1.55e-05	9.37e-05	CcSEcCtD
Zaleplon—Rash—Triamcinolone—asthma	1.55e-05	9.36e-05	CcSEcCtD
Zaleplon—Dermatitis—Triamcinolone—asthma	1.55e-05	9.35e-05	CcSEcCtD
Zaleplon—Rash—Methylprednisolone—asthma	1.54e-05	9.34e-05	CcSEcCtD
Zaleplon—Dermatitis—Methylprednisolone—asthma	1.54e-05	9.33e-05	CcSEcCtD
Zaleplon—AOX1—Metabolism—LTA4H—asthma	1.54e-05	0.00278	CbGpPWpGaD
Zaleplon—Urticaria—Prednisone—asthma	1.54e-05	9.32e-05	CcSEcCtD
Zaleplon—Headache—Triamcinolone—asthma	1.54e-05	9.3e-05	CcSEcCtD
Zaleplon—Headache—Methylprednisolone—asthma	1.53e-05	9.28e-05	CcSEcCtD
Zaleplon—Abdominal pain—Prednisone—asthma	1.53e-05	9.27e-05	CcSEcCtD
Zaleplon—Body temperature increased—Prednisone—asthma	1.53e-05	9.27e-05	CcSEcCtD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ATP4A—asthma	1.52e-05	0.00275	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—SLC30A8—asthma	1.52e-05	0.00275	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—SLC26A4—asthma	1.52e-05	0.00275	CbGpPWpGaD
Zaleplon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	1.51e-05	0.00273	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—BDNF—asthma	1.48e-05	0.00266	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—ADCY2—asthma	1.47e-05	0.00266	CbGpPWpGaD
Zaleplon—Dizziness—Betamethasone—asthma	1.47e-05	8.91e-05	CcSEcCtD
Zaleplon—Dizziness—Dexamethasone—asthma	1.47e-05	8.91e-05	CcSEcCtD
Zaleplon—GABRA1—Neuronal System—ALDH2—asthma	1.46e-05	0.00263	CbGpPWpGaD
Zaleplon—Nausea—Triamcinolone—asthma	1.46e-05	8.82e-05	CcSEcCtD
Zaleplon—Nausea—Methylprednisolone—asthma	1.45e-05	8.8e-05	CcSEcCtD
Zaleplon—CYP3A5—Biological oxidations—ALDH2—asthma	1.43e-05	0.00257	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—SLC30A8—asthma	1.43e-05	0.00257	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ATP4A—asthma	1.43e-05	0.00257	CbGpPWpGaD
Zaleplon—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—asthma	1.42e-05	0.00256	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ATP4A—asthma	1.42e-05	0.00256	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—SLC30A8—asthma	1.42e-05	0.00256	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—ADCY2—asthma	1.41e-05	0.00255	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL10—asthma	1.41e-05	0.00254	CbGpPWpGaD
Zaleplon—Rash—Betamethasone—asthma	1.4e-05	8.49e-05	CcSEcCtD
Zaleplon—Rash—Dexamethasone—asthma	1.4e-05	8.49e-05	CcSEcCtD
Zaleplon—Dermatitis—Betamethasone—asthma	1.4e-05	8.49e-05	CcSEcCtD
Zaleplon—Dermatitis—Dexamethasone—asthma	1.4e-05	8.49e-05	CcSEcCtD
Zaleplon—Headache—Betamethasone—asthma	1.39e-05	8.44e-05	CcSEcCtD
Zaleplon—Headache—Dexamethasone—asthma	1.39e-05	8.44e-05	CcSEcCtD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ATP4A—asthma	1.39e-05	0.00251	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—SLC30A8—asthma	1.39e-05	0.00251	CbGpPWpGaD
Zaleplon—Asthenia—Prednisone—asthma	1.39e-05	8.42e-05	CcSEcCtD
Zaleplon—Pruritus—Prednisone—asthma	1.37e-05	8.3e-05	CcSEcCtD
Zaleplon—CYP3A5—Biological oxidations—GSTT1—asthma	1.36e-05	0.00245	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ARG1—asthma	1.35e-05	0.00243	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—SLC26A4—asthma	1.33e-05	0.0024	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—ADCY2—asthma	1.33e-05	0.00239	CbGpPWpGaD
Zaleplon—Nausea—Dexamethasone—asthma	1.32e-05	8e-05	CcSEcCtD
Zaleplon—Nausea—Betamethasone—asthma	1.32e-05	8e-05	CcSEcCtD
Zaleplon—GABRB3—Neuronal System—ADCY2—asthma	1.32e-05	0.00237	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—GSTP1—asthma	1.3e-05	0.00235	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—NR3C1—asthma	1.3e-05	0.00235	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—ADCY2—asthma	1.29e-05	0.00233	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—GSTP1—asthma	1.29e-05	0.00232	CbGpPWpGaD
Zaleplon—Dizziness—Prednisone—asthma	1.28e-05	7.76e-05	CcSEcCtD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—asthma	1.25e-05	0.00225	CbGpPWpGaD
Zaleplon—CYP3A4—Tryptophan metabolism—CAT—asthma	1.22e-05	0.00221	CbGpPWpGaD
Zaleplon—Rash—Prednisone—asthma	1.22e-05	7.4e-05	CcSEcCtD
Zaleplon—Dermatitis—Prednisone—asthma	1.22e-05	7.39e-05	CcSEcCtD
Zaleplon—AOX1—Metabolism—ALDH7A1—asthma	1.22e-05	0.0022	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ATP4A—asthma	1.22e-05	0.00219	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—SLC30A8—asthma	1.22e-05	0.00219	CbGpPWpGaD
Zaleplon—Headache—Prednisone—asthma	1.21e-05	7.35e-05	CcSEcCtD
Zaleplon—CYP3A7—Biological oxidations—GSTM1—asthma	1.2e-05	0.00216	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—GSTM1—asthma	1.18e-05	0.00213	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ARG2—asthma	1.17e-05	0.0021	CbGpPWpGaD
Zaleplon—CYP3A5—Phase 1 - Functionalization of compounds—POMC—asthma	1.15e-05	0.00208	CbGpPWpGaD
Zaleplon—Nausea—Prednisone—asthma	1.15e-05	6.97e-05	CcSEcCtD
Zaleplon—GABRA1—Neuronal System—ADCY2—asthma	1.13e-05	0.00203	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—CARM1—asthma	1.02e-05	0.00185	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL6R—asthma	9.71e-06	0.00175	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALOX15—asthma	9.68e-06	0.00174	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALOX5AP—asthma	9.68e-06	0.00174	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—CARM1—asthma	9.61e-06	0.00173	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—CARM1—asthma	9.54e-06	0.00172	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—GSTP1—asthma	9.43e-06	0.0017	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—CARM1—asthma	9.37e-06	0.00169	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—GSTP1—asthma	9.3e-06	0.00167	CbGpPWpGaD
Zaleplon—AOX1—Disease—DCN—asthma	9.24e-06	0.00166	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CHAT—asthma	9.24e-06	0.00166	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—GSTM1—asthma	8.66e-06	0.00156	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—GSTM1—asthma	8.54e-06	0.00154	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—POMC—asthma	8.47e-06	0.00153	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALOX5—asthma	8.23e-06	0.00148	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—CARM1—asthma	8.19e-06	0.00148	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LTC4S—asthma	7.99e-06	0.00144	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CARM1—asthma	7.86e-06	0.00141	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—DCN—asthma	7.74e-06	0.00139	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CXCL8—asthma	7.7e-06	0.00139	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—STAT3—asthma	7.7e-06	0.00139	CbGpPWpGaD
Zaleplon—AOX1—Disease—CYBA—asthma	7.61e-06	0.00137	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ADCY2—asthma	7.6e-06	0.00137	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALDH2—asthma	7.53e-06	0.00136	CbGpPWpGaD
Zaleplon—AOX1—Disease—PARP1—asthma	7.45e-06	0.00134	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL1B—asthma	7.39e-06	0.00133	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTT1—asthma	7.16e-06	0.00129	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ADCY2—asthma	7.12e-06	0.00128	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ADCY2—asthma	7.08e-06	0.00127	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS1—asthma	7.01e-06	0.00126	CbGpPWpGaD
Zaleplon—AOX1—Disease—ADCY2—asthma	6.96e-06	0.00125	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ADCY2—asthma	6.95e-06	0.00125	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LTA4H—asthma	6.93e-06	0.00125	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—ALDH2—asthma	6.65e-06	0.0012	CbGpPWpGaD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	6.61e-06	0.00119	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—HMOX1—asthma	6.39e-06	0.00115	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTT1—asthma	6.32e-06	0.00114	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—VEGFA—asthma	6.26e-06	0.00113	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—POMC—asthma	6.12e-06	0.0011	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ADCY2—asthma	6.07e-06	0.00109	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ARG1—asthma	6.05e-06	0.00109	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—HMOX1—asthma	5.99e-06	0.00108	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—NQO1—asthma	5.95e-06	0.00107	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—HMOX1—asthma	5.95e-06	0.00107	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—HMOX1—asthma	5.84e-06	0.00105	CbGpPWpGaD
Zaleplon—AOX1—Disease—ITPR1—asthma	5.83e-06	0.00105	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ADCY2—asthma	5.83e-06	0.00105	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LTC4S—asthma	5.77e-06	0.00104	CbGpPWpGaD
Zaleplon—AOX1—Disease—CD86—asthma	5.56e-06	0.001	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALDH7A1—asthma	5.47e-06	0.000986	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—TNF—asthma	5.36e-06	0.000966	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	5.36e-06	0.000965	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ARG2—asthma	5.25e-06	0.000945	CbGpPWpGaD
Zaleplon—AOX1—Disease—SMAD3—asthma	5.24e-06	0.000944	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—HMOX1—asthma	5.11e-06	0.000919	CbGpPWpGaD
Zaleplon—AOX1—Disease—PPP2CA—asthma	5.02e-06	0.000904	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LTA4H—asthma	5.01e-06	0.000901	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTP1—asthma	4.97e-06	0.000894	CbGpPWpGaD
Zaleplon—AOX1—Disease—CCR5—asthma	4.93e-06	0.000887	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—HMOX1—asthma	4.9e-06	0.000882	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ITPR1—asthma	4.89e-06	0.00088	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CAT—asthma	4.83e-06	0.00087	CbGpPWpGaD
Zaleplon—AOX1—Disease—PDGFB—asthma	4.69e-06	0.000844	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTM1—asthma	4.56e-06	0.000822	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PLA2G4A—asthma	4.56e-06	0.000822	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTP1—asthma	4.38e-06	0.000789	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ARG1—asthma	4.38e-06	0.000788	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALOX15—asthma	4.35e-06	0.000783	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALOX5AP—asthma	4.35e-06	0.000783	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL6—asthma	4.33e-06	0.000779	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTP1—asthma	4.32e-06	0.000778	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PPP2CA—asthma	4.2e-06	0.000757	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS2—asthma	4.18e-06	0.000752	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CHAT—asthma	4.15e-06	0.000747	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTM1—asthma	4.03e-06	0.000725	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTM1—asthma	3.97e-06	0.000715	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALDH7A1—asthma	3.96e-06	0.000713	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ALB—asthma	3.84e-06	0.000691	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ARG2—asthma	3.79e-06	0.000683	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6R—asthma	3.76e-06	0.000676	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALOX5—asthma	3.7e-06	0.000666	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ALB—asthma	3.6e-06	0.000647	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ALB—asthma	3.57e-06	0.000643	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CARM1—asthma	3.53e-06	0.000635	CbGpPWpGaD
Zaleplon—AOX1—Disease—SERPINE1—asthma	3.52e-06	0.000633	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ALB—asthma	3.51e-06	0.000632	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—DCN—asthma	3.48e-06	0.000626	CbGpPWpGaD
Zaleplon—AOX1—Disease—RHOA—asthma	3.39e-06	0.000611	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALDH2—asthma	3.38e-06	0.000609	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS3—asthma	3.36e-06	0.000605	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—POMC—asthma	3.23e-06	0.000581	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTT1—asthma	3.22e-06	0.000579	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALOX5AP—asthma	3.14e-06	0.000566	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALOX15—asthma	3.14e-06	0.000566	CbGpPWpGaD
Zaleplon—AOX1—Disease—CD4—asthma	3.09e-06	0.000557	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTGS2—asthma	3.07e-06	0.000553	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ALB—asthma	3.07e-06	0.000552	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CHAT—asthma	3e-06	0.00054	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALB—asthma	2.94e-06	0.00053	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—POMC—asthma	2.85e-06	0.000513	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—NOS3—asthma	2.81e-06	0.000506	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LTC4S—asthma	2.68e-06	0.000483	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTEN—asthma	2.68e-06	0.000482	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NQO1—asthma	2.67e-06	0.000481	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALOX5—asthma	2.67e-06	0.000481	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ADCY2—asthma	2.62e-06	0.000471	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS2—asthma	2.57e-06	0.000463	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CARM1—asthma	2.55e-06	0.000459	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—DCN—asthma	2.51e-06	0.000453	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALDH2—asthma	2.44e-06	0.00044	CbGpPWpGaD
Zaleplon—AOX1—Disease—STAT3—asthma	2.4e-06	0.000431	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LTA4H—asthma	2.33e-06	0.000419	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTT1—asthma	2.33e-06	0.000419	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTEN—asthma	2.24e-06	0.000404	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTP1—asthma	2.23e-06	0.000402	CbGpPWpGaD
Zaleplon—AOX1—Disease—TGFB1—asthma	2.22e-06	0.0004	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HMOX1—asthma	2.2e-06	0.000396	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ITPR1—asthma	2.19e-06	0.000395	CbGpPWpGaD
Zaleplon—AOX1—Disease—EGFR—asthma	2.18e-06	0.000392	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CAT—asthma	2.17e-06	0.000391	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTM1—asthma	2.05e-06	0.000369	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PLA2G4A—asthma	2.05e-06	0.000369	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ARG1—asthma	2.03e-06	0.000366	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NQO1—asthma	1.93e-06	0.000348	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ADCY2—asthma	1.89e-06	0.000341	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPP2CA—asthma	1.89e-06	0.00034	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALDH7A1—asthma	1.84e-06	0.000331	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ARG2—asthma	1.76e-06	0.000318	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6—asthma	1.67e-06	0.000301	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTP1—asthma	1.61e-06	0.00029	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HMOX1—asthma	1.59e-06	0.000286	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ITPR1—asthma	1.59e-06	0.000286	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CAT—asthma	1.57e-06	0.000282	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTM1—asthma	1.48e-06	0.000267	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLA2G4A—asthma	1.48e-06	0.000267	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALOX15—asthma	1.46e-06	0.000263	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALOX5AP—asthma	1.46e-06	0.000263	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—POMC—asthma	1.45e-06	0.000261	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CHAT—asthma	1.39e-06	0.000251	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPP2CA—asthma	1.36e-06	0.000246	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALB—asthma	1.32e-06	0.000238	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NOS3—asthma	1.26e-06	0.000227	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALOX5—asthma	1.24e-06	0.000224	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CARM1—asthma	1.19e-06	0.000213	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—DCN—asthma	1.17e-06	0.00021	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS2—asthma	1.16e-06	0.000208	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALDH2—asthma	1.14e-06	0.000205	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTT1—asthma	1.08e-06	0.000195	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—POMC—asthma	1.05e-06	0.000189	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTEN—asthma	1.01e-06	0.000181	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALB—asthma	9.54e-07	0.000172	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NOS3—asthma	9.13e-07	0.000164	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NQO1—asthma	8.98e-07	0.000162	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ADCY2—asthma	8.79e-07	0.000158	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS2—asthma	8.35e-07	0.00015	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTP1—asthma	7.49e-07	0.000135	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HMOX1—asthma	7.39e-07	0.000133	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ITPR1—asthma	7.37e-07	0.000133	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CAT—asthma	7.29e-07	0.000131	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTEN—asthma	7.28e-07	0.000131	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLA2G4A—asthma	6.89e-07	0.000124	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTM1—asthma	6.89e-07	0.000124	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPP2CA—asthma	6.34e-07	0.000114	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—POMC—asthma	4.87e-07	8.76e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALB—asthma	4.44e-07	7.99e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NOS3—asthma	4.24e-07	7.64e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS2—asthma	3.88e-07	6.99e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTEN—asthma	3.39e-07	6.1e-05	CbGpPWpGaD
